Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post‐hoc analysis of the Hokusai‐ VTE Cancer study

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

(2018) Gary E. Raskob et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study

(2017) Luis Jara-Palomares et al.   THROMBOSIS RESEARCH

Antithrombotic Therapy for VTE Disease

(2016) Clive Kearon et al.   CHEST

Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?

(2016) Alok A. Khorana et al.   THROMBOSIS RESEARCH

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014

(2015) Gary H. Lyman et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study

(2015) C. W. Francis et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting

(2012) Vicky Springmann et al.   THROMBOSIS AND HAEMOSTASIS

Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis

(2012) Freesia Horsted et al.   PLOS MEDICINE